US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Firmagon

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55566-8403-01 D-1016-2022
Class II · Moderate risk Terminated

Firmagon

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55566-8303-01 D-1015-2022
Class II · Moderate risk Terminated

Epinephrine Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-101-02 D-1014-2022
Class II · Moderate risk Terminated

Epinephrine Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-102-02 D-1013-2022
Class II · Moderate risk Terminated

EPI-Pen Jr

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-501-02 D-1012-2022
Class II · Moderate risk Terminated

Dihydroergotamine Mesylate

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0574-0850-10 D-1011-2022
Class II · Moderate risk Terminated

Epidural Tray

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office D-1010-2022
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-113-10 D-1009-2022
Class II · Moderate risk Terminated

Betadine 5%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0411-30 D-1008-2022
Class II · Moderate risk Terminated

Sumatriptan Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0173-01 D-1007-2022
Class II · Moderate risk Terminated

Arzol

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 12870-0001-02 D-1006-2022
Class II · Moderate risk Terminated

Olanzapine single dose vial Lyophilized

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0308-01 D-1005-2022
Class II · Moderate risk Terminated

Lidocaine Patch

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 42858-0118-30 D-1004-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0171-10 D-1002-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0250-50 D-1001-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0249-50 D-1000-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0170-30 D-0999-2022
Class II · Moderate risk Terminated

Bupivacaine HCl Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-169-10 D-0998-2022
Class II · Moderate risk Terminated

Azithromycin for Injection USP Vial

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-174-10 D-0997-2022
Class II · Moderate risk Terminated

Topex

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0699-5116-01 D-0996-2022
Class II · Moderate risk Terminated

TobraDex

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0078-0876-01 D-0995-2022
Class II · Moderate risk Terminated

Miocol-E

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 24208-539-20 D-0994-2022
Class II · Moderate risk Terminated

Epi-Pen 2-Pak

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-500-02 D-0993-2022
Class II · Moderate risk Terminated

Losartan Potassium Tab. USP 50mg

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Preferred Pharmaceuticals, Inc. D-0789-2022